Related Experiment Video

Updated: May 21, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Non-variceal gastrointestinal bleeding in patients with liver cirrhosis: a review

M Kalafateli1, C K Triantos, V Nikolopoulou

  • 1Department of Gastroenterology, University Hospital of Patras, Patras, Greece. mariakalaf@hotmail.com

Digestive Diseases and Sciences
|June 5, 2012
PubMed

Insights

Non-variceal gastrointestinal bleeding in cirrhosis is poorly understood, with limited data on its prevalence and effective treatments. More research is needed to guide management strategies for these patients.

Area of Science:

  • Gastroenterology
  • Hepatology
  • Internal Medicine

Background:

  • Non-variceal gastrointestinal (NVGI) bleeding in cirrhosis can lead to severe complications.
  • Understanding NVGI bleeding is crucial for managing patients with liver disease.

Purpose of the Study:

  • To review the current literature on non-variceal gastrointestinal bleeding in patients with cirrhosis.

Main Methods:

  • Comprehensive literature search of MEDLINE, Scopus, and ISI Web of Knowledge.
  • Inclusion of studies on various NVGI bleeding causes like portal hypertensive gastropathy, gastric vascular ectasia, peptic ulcers, and others.

Main Results:

  • Portal hypertensive gastropathy and gastric vascular ectasia are common but rarely cause acute bleeding.
  • Peptic ulcers are frequent in cirrhosis but contribute less to acute bleeding; H. pylori role is unclear.
  • Portal hypertensive colopathy and hemorrhoids are common in lower GI bleeding, but data are scarce.

Conclusions:

  • There is a surprising lack of data on NVGI bleeding in liver cirrhosis.
  • Large epidemiological and randomized controlled trials are essential to define prevalence, incidence, and optimal therapeutic algorithms.
Abstract

More Related Videos

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...